Related Experiment Videos
The case for bladder botulinum toxin application
Dae Kyung Kim1, Catherine A Thomas, Christopher Smith
1Department of Urology, Eulji University School of Medicine, 1306 Dunsandong Seogu, Daejeon, Korea.
Abstract:
Botulinum toxin (BoNT) has been shown to be and effective agent in suppressing detrusor overactivity due to neurogenic causes. Recently, BoNT has been extended to patients who have idiopathic detrusor overactivity. This article reviews the use of BoNT to treat disorders of neurogenic detrusor overactivity and establishes BoNT as a therapeutic modality to treat idiopathic bladder overactivity. It is important to remember that the application of BoNT in the lower urinary tract is not approved by the regulatory agencies and caution should be applied until larger randomized clinical studies are completed.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Skeletal Muscle Relaxants: Therapeutic Uses
Urinary Tract Infection IV: Nursing Management
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Imaging Studies VI: Voiding Cystourethrography and Cystography
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...